Download PDF
CC BY-NC-ND 4.0 · World J Nucl Med 2016; 15(03): 203-205
DOI: 10.4103/1450-1147.172303
Case report

Use of marrow scintigraphy to confirm compensatory marrow rather than active myeloma

Twyla Bartel
Global Advanced Imaging, PLLC, Little Rock, Arkansas, USA
,
Tracy Yarbrough
Global Advanced Imaging, PLLC, Little Rock, Arkansas, USA
,
Lorraine De Blanche
1   Central Arkansas Radiation Therapy Institute, Little Rock, Arkansas, USA
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints

We present the case of a 40-year-old male with multiple myeloma for whom bone marrow scintigraphy was utilized to help differentiate between active bony myelomatous disease versus treated lesions with compensatory marrow uptake. This case demonstrates technetium (Tc-99m) sulfur colloid imaging as an inexpensive technique to quickly distinguish between active focal bone disease and reactive marrow.

Keywords

Fluorodeoxyglucose - marrow scintigraphy - multiple myeloma - plasmacytoma


Publication History

Article published online:
19 May 2022

© 2016. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India